Scholars@Duke

LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker

Publication ,  Journal Article
Chen, D; Sun, Y; Wei, Y; Zhang, P; Rezaeian, AH; Teruya-Feldstein, J; Gupta, S; Liang, H; Lin, H-K; Hung, M-C; Ma, L
Published in: Nature Medicine
October 2012
Published version (DOI) Publisher Link

Duke Scholars

Hui-Kuan Lin
Author Hui-Kuan Lin Pathology
Altmetric Attention Stats
Dimensions Citation Stats

Published In

Nature Medicine

DOI

10.1038/nm.2940

EISSN

1546-170X

ISSN

1078-8956

Publication Date

October 2012

Volume

18

Issue

10

Start / End Page

1511 / 1517

Publisher

Springer Science and Business Media LLC

Related Subject Headings

  • Immunology
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chen, D., Sun, Y., Wei, Y., Zhang, P., Rezaeian, A. H., Teruya-Feldstein, J., … Ma, L. (2012). LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker. Nature Medicine, 18(10), 1511–1517. https://doi.org/10.1038/nm.2940
Chen, Dahu, Yutong Sun, Yongkun Wei, Peijing Zhang, Abdol Hossein Rezaeian, Julie Teruya-Feldstein, Sumeet Gupta, et al. “LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker.” Nature Medicine 18, no. 10 (October 2012): 1511–17. https://doi.org/10.1038/nm.2940.
Chen D, Sun Y, Wei Y, Zhang P, Rezaeian AH, Teruya-Feldstein J, et al. LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker. Nature Medicine. 2012 Oct;18(10):1511–7.
Chen, Dahu, et al. “LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker.” Nature Medicine, vol. 18, no. 10, Springer Science and Business Media LLC, Oct. 2012, pp. 1511–17. Crossref, doi:10.1038/nm.2940.
Chen D, Sun Y, Wei Y, Zhang P, Rezaeian AH, Teruya-Feldstein J, Gupta S, Liang H, Lin H-K, Hung M-C, Ma L. LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker. Nature Medicine. Springer Science and Business Media LLC; 2012 Oct;18(10):1511–1517.

Published In

Nature Medicine

DOI

10.1038/nm.2940

EISSN

1546-170X

ISSN

1078-8956

Publication Date

October 2012

Volume

18

Issue

10

Start / End Page

1511 / 1517

Publisher

Springer Science and Business Media LLC

Related Subject Headings

  • Immunology
  • 11 Medical and Health Sciences